Loss of activity of plasma platelet-activating factor acetylhydrolase due to a novel Gln281-->Arg mutation.
about
The Ile198Thr and Ala379Val variants of plasmatic PAF-acetylhydrolase impair catalytical activities and are associated with atopy and asthmaMolecular Model of Plasma PAF Acetylhydrolase-Lipoprotein Association: Insights from the Structure.Genetic invalidation of Lp-PLA2 as a therapeutic target: Large-scale study of five functional Lp-PLA2-lowering alleles.Deficiency of platelet-activating factor acetylhydrolase is a severity factor for asthmaPAF acetylhydrolase gene polymorphisms and asthma severity.Platelet-activating factor, a pleiotrophic mediator of physiological and pathological processes.Modulation of oxidative stress, inflammation, and atherosclerosis by lipoprotein-associated phospholipase A2Functional Consequences of Mutations and Polymorphisms in the Coding Region of the PAF Acetylhydrolase (PAF-AH) Gene.Pharmacogenetic meta-analysis of baseline risk factors, pharmacodynamic, efficacy and tolerability endpoints from two large global cardiovascular outcomes trials for darapladib.Altered distribution of plasma PAF-AH between HDLs and other lipoproteins in hyperlipidemia and diabetes mellitus.The PON1 M55L gene polymorphism is associated with reduced HDL-associated PAF-AH activity.Platelet activating factor-acetylhydrolase (PAF-AH) activity and HDL levels, but not PAF-AH gene polymorphisms, are associated with successful aging in Sicilian octogenarians.Protection against oxidative stress-induced hepatic injury by intracellular type II platelet-activating factor acetylhydrolase by metabolism of oxidized phospholipids in vivo.Plasma platelet-activating factor-acetyl hydrolase activity and the levels of free forms of biomarker of lipid peroxidation in cerebrospinal fluid of patients with aneurysmal subarachnoid hemorrhage.
P2860
Q24540170-8274A8B6-DC97-489D-A3BA-478D9416B96CQ33664201-A0B4A122-2B40-4AE1-93BE-4A18610EE3BCQ33768940-B0089195-6BB8-41E1-BA26-2EC862F1AEABQ33848692-E69B9490-2D94-47E3-89C6-EFB7289AC988Q34355213-793ED0E6-C37D-46A7-9840-27AE4FDC5D39Q35621992-19237EAF-9499-4D88-9E89-BF05C3F3369BQ36145180-6CE69F65-D420-4008-9308-76F2C74787B2Q37689865-556E248E-67EF-45F4-8D0E-625FA78E0012Q42339104-45F4A2A6-CF7D-46E0-8DC2-D7E25E48F871Q44516292-96E98C86-3401-45D7-A8E4-228BD1BB5795Q44516301-8C3E4DFB-783E-4263-9075-00AFD47FDCD7Q46631117-F30CB3E9-28C0-4B3F-9FFD-7A10675B2D46Q46891942-C29F7E30-A7E6-429B-AF9C-58C0287D948BQ55054784-C89F9DBD-5B68-4D07-9770-5D7CB284A99A
P2860
Loss of activity of plasma platelet-activating factor acetylhydrolase due to a novel Gln281-->Arg mutation.
description
1997 nî lūn-bûn
@nan
1997 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Loss of activity of plasma pla ...... a novel Gln281-->Arg mutation.
@ast
Loss of activity of plasma pla ...... a novel Gln281-->Arg mutation.
@en
Loss of activity of plasma pla ...... a novel Gln281-->Arg mutation.
@nl
type
label
Loss of activity of plasma pla ...... a novel Gln281-->Arg mutation.
@ast
Loss of activity of plasma pla ...... a novel Gln281-->Arg mutation.
@en
Loss of activity of plasma pla ...... a novel Gln281-->Arg mutation.
@nl
prefLabel
Loss of activity of plasma pla ...... a novel Gln281-->Arg mutation.
@ast
Loss of activity of plasma pla ...... a novel Gln281-->Arg mutation.
@en
Loss of activity of plasma pla ...... a novel Gln281-->Arg mutation.
@nl
P356
P1476
Loss of activity of plasma pla ...... a novel Gln281-->Arg mutation.
@en
P2093
P304
P356
10.1006/BBRC.1997.7047
P407
P577
1997-07-01T00:00:00Z